Related Experiment Video
Updated: Dec 30, 2025

06:55
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
19.3K
Complementary approaches to study NKT cells in cancer.
Jay A Berzofsky1, Purevdorj B Olkhanud1, Masaki Terabe2
1Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Methods in Enzymology
|January 18, 2020
Summary
Natural killer T (NKT) cells bridge innate and adaptive immunity by recognizing lipid antigens. Newer research tools enhance the study of NKT cells in cancer immunology and immunotherapy.
Area of Science:
- Immunology
- Cellular immunology
- Cancer immunology
Background:
- Natural killer T (NKT) cells are a distinct T cell population recognizing lipid antigens via CD1d molecules.
- NKT cells link innate and adaptive immunity, acting as rapid responders and regulators of immune responses.
- Type I and type II NKT cells, distinguished by their T cell receptors (TCRs), have opposing roles in tumor immunity.
Purpose of the Study:
- To describe novel tools and approaches for studying NKT cells.
- To highlight the application of these tools in understanding NKT cell roles in cancer immunology and immunotherapy.
Main Methods:
- Utilized transgenic and knock-out mouse models.
- Employed CD1d tetramers loaded with ligands for NKT cell subsets.
- Developed and used antibodies and NKT cell hybridomas for NKT cell research.
Main Results:
- Newer research tools have significantly advanced the study of NKT cells, particularly in mouse models.
- These tools facilitate the investigation of NKT cell functions in the context of tumors and microbial infections.
- The cross-regulation between type I and type II NKT cells has been further elucidated.
Conclusions:
- Advancements in research tools have overcome previous limitations in studying NKT cells.
- These tools are crucial for dissecting the complex roles of NKT cells in cancer immunology.
- Further research using these tools promises to enhance cancer immunotherapy strategies targeting NKT cells.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

